Melissa Kerr

机构：Orygen Youth Health, Mental Health Australia

发表论文 58 篇 · 总被引 1049 次 · h-index 19

代表论文

• Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis (2024 · Schizophrenia Bulletin · 被引 82)
• A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis (2023 · JAMA Psychiatry · 被引 47)
• Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (2023 · Early Intervention in Psychiatry · 被引 44)
• Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial (2023 · Translational Psychiatry · 被引 22)
• Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (2023 · medRxiv · 被引 21)
• Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging (2022 · Australasian Journal of Dermatology · 被引 15)